| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,301 |
17,596 |
$2.31M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,720 |
4,882 |
$789K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,980 |
1,477 |
$778K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,853 |
4,405 |
$571K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,087 |
884 |
$347K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,167 |
1,734 |
$341K |
| 70450 |
Computed tomography, head or brain; without contrast material |
762 |
603 |
$227K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
548 |
440 |
$167K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,470 |
2,145 |
$99K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,419 |
2,067 |
$73K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
271 |
219 |
$57K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
421 |
385 |
$49K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
408 |
314 |
$45K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
115 |
100 |
$40K |
| 81513 |
|
218 |
188 |
$34K |
| 80053 |
Comprehensive metabolic panel |
3,095 |
2,533 |
$29K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,223 |
3,612 |
$26K |
| 71046 |
Radiologic examination, chest; 2 views |
2,159 |
1,917 |
$20K |
| 84443 |
Thyroid stimulating hormone (TSH) |
798 |
704 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
9,469 |
7,796 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,454 |
5,351 |
$11K |
| 80061 |
Lipid panel |
735 |
677 |
$9K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
90 |
71 |
$9K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
273 |
253 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,869 |
3,346 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
557 |
525 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
274 |
255 |
$6K |
| 10060 |
|
31 |
28 |
$6K |
| 72100 |
|
192 |
179 |
$5K |
| 73030 |
|
311 |
274 |
$5K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
43 |
38 |
$4K |
| 85027 |
|
839 |
670 |
$4K |
| 83735 |
|
1,020 |
785 |
$4K |
| 82607 |
|
155 |
148 |
$3K |
| 82248 |
|
1,572 |
1,259 |
$3K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
41 |
26 |
$3K |
| 71045 |
Radiologic examination, chest; single view |
1,275 |
1,051 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,580 |
2,085 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
600 |
505 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
20 |
16 |
$2K |
| 73630 |
|
368 |
316 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
12 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,445 |
1,239 |
$2K |
| 73610 |
|
315 |
279 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,969 |
2,291 |
$2K |
| 81001 |
|
3,389 |
2,860 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,095 |
1,571 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
600 |
505 |
$1K |
| 85055 |
|
123 |
97 |
$1K |
| 84484 |
|
1,585 |
1,272 |
$1K |
| 73130 |
|
294 |
234 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
536 |
445 |
$1K |
| 83540 |
|
115 |
109 |
$1K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
25 |
24 |
$1K |
| 83690 |
|
1,676 |
1,307 |
$1K |
| 76830 |
Ultrasound, transvaginal |
33 |
29 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
66 |
51 |
$1K |
| 73110 |
|
109 |
93 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,913 |
1,512 |
$979.43 |
| 81025 |
|
2,735 |
2,297 |
$917.94 |
| 84702 |
|
355 |
277 |
$911.96 |
| 83880 |
|
308 |
258 |
$906.68 |
| 84439 |
|
66 |
59 |
$851.02 |
| 90715 |
|
37 |
26 |
$787.30 |
| 85610 |
|
231 |
185 |
$765.46 |
| 82077 |
|
71 |
52 |
$759.83 |
| 73502 |
|
14 |
14 |
$732.76 |
| 81003 |
|
1,298 |
1,078 |
$655.03 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
341 |
297 |
$647.69 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,418 |
1,822 |
$644.88 |
| 82570 |
|
67 |
60 |
$635.73 |
| 87481 |
|
218 |
188 |
$545.41 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
18 |
18 |
$526.81 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
324 |
314 |
$526.07 |
| 83605 |
|
442 |
345 |
$509.61 |
| 73564 |
|
199 |
166 |
$499.23 |
| 82805 |
|
25 |
16 |
$445.83 |
| 87210 |
|
152 |
131 |
$366.90 |
| 82728 |
|
19 |
17 |
$305.98 |
| 85379 |
|
482 |
390 |
$298.33 |
| 82043 |
|
48 |
43 |
$287.11 |
| 96376 |
|
266 |
192 |
$280.31 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
789 |
550 |
$269.38 |
| 83550 |
|
41 |
40 |
$264.38 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
16 |
16 |
$254.34 |
| 80076 |
|
26 |
25 |
$243.90 |
| 87040 |
|
113 |
79 |
$189.23 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
41 |
27 |
$175.05 |
| 85730 |
|
91 |
66 |
$170.47 |
| 85652 |
|
32 |
30 |
$154.05 |
| 84703 |
|
165 |
143 |
$150.55 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,325 |
1,829 |
$103.07 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,576 |
1,298 |
$97.21 |
| 87077 |
|
15 |
13 |
$87.74 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
398 |
290 |
$73.59 |
| 87186 |
|
13 |
12 |
$70.90 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
147 |
119 |
$58.26 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
518 |
402 |
$39.09 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
111 |
93 |
$35.36 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
337 |
248 |
$31.26 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,607 |
1,216 |
$26.66 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
48 |
40 |
$17.58 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
507 |
388 |
$16.11 |
| 81015 |
|
27 |
19 |
$6.05 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
32 |
21 |
$5.49 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
184 |
148 |
$5.18 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
57 |
50 |
$0.09 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
14 |
12 |
$0.04 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
14 |
13 |
$0.00 |